Rasio rega marang bathi KORU Medical Systems, Inc. (KRMD)

KORU Medical Systems (KRMD) develops home infusion systems, generating revenue through the continuous sale of ancillary consumables. The price trend reflected below with the -215.90 indicator confirms its status as a leader in the mechanical drug delivery segment, which is protected by patents and FDA certifications. Business stability relies on a narrow niche of wearable devices, which aligns effectively with the global medical shift toward outpatient care.

The P/E ratio is calculated as the ratio of market capitalization to net income, determining the cost of one dollar of annual earnings. The current value of -215.90 reflects market expectations regarding the monetization rates of medical technologies. For KORU Medical Systems (KRMD), this metric depends directly on the efficiency of long-term partnerships with pharma behemoths without the involvement of external assets. An analysis based on the company's historical average P/E allows for an objective assessment of the premium paid for organic growth.